These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation. Laemmle A; Hahn D; Hu L; Rüfenacht V; Gautschi M; Leibundgut K; Nuoffer JM; Häberle J Mol Genet Metab; 2015 Mar; 114(3):438-44. PubMed ID: 25639153 [TBL] [Abstract][Full Text] [Related]
44. Nutritional influence on serum ammonia in young patients receiving sodium valproate. Laub MC Epilepsia; 1986; 27(1):55-9. PubMed ID: 3081337 [TBL] [Abstract][Full Text] [Related]
45. Effects of 2,4-dinitrophenol on renal ammoniagenesis in the rat. Imler M; Chabrier G; Marescaux C; Warter JM Eur J Pharmacol; 1986 Apr; 123(2):175-9. PubMed ID: 3086107 [TBL] [Abstract][Full Text] [Related]
46. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats. Yamamura N; Imura K; Naganuma H; Nishimura K Drug Metab Dispos; 1999 Jun; 27(6):724-30. PubMed ID: 10348803 [TBL] [Abstract][Full Text] [Related]
47. Effect of valproic acid on glycine conjugation of benzoic acid. Gregus Z; Fekete T; Varga F; Klaassen CD J Pharmacol Exp Ther; 1993 Dec; 267(3):1068-75. PubMed ID: 8263766 [TBL] [Abstract][Full Text] [Related]
48. The renal origin of sodium valproate-induced hyperammonemia in fasting humans. Warter JM; Brandt C; Marescaux C; Rumbach L; Micheletti G; Chabrier G; Krieger J; Imler M Neurology; 1983 Sep; 33(9):1136-40. PubMed ID: 6412158 [TBL] [Abstract][Full Text] [Related]
49. Carbamoyl-phosphate synthetase I activity and ureagenesis in regenerating liver of the normal rat. Goodman MW; Zieve L Am J Physiol; 1985 May; 248(5 Pt 1):G501-6. PubMed ID: 3993779 [TBL] [Abstract][Full Text] [Related]
50. Fatal hyperammonemia in a patient with systemic lupus erythematosus. Ichikawa H; Amano T; Kawabata K; Kushiro M; Wada J; Nagake Y; Makino H Intern Med; 1998 Aug; 37(8):700-3. PubMed ID: 9745859 [TBL] [Abstract][Full Text] [Related]
51. [In vitro activation by dithiothreitol and thioredoxins of carbamyl phosphate synthetase-I in rat liver]. Gautier C; Habechi Z; Balangé AP; Vaillant R C R Acad Sci III; 1984; 299(20):849-52. PubMed ID: 6441619 [TBL] [Abstract][Full Text] [Related]
52. Effect of valproic acid on zinc metabolism in the rat. Daffron JC; Kasarskis EJ Toxicol Lett; 1984 Dec; 23(3):321-5. PubMed ID: 6441315 [TBL] [Abstract][Full Text] [Related]
53. Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy. Zhu X; Li X; Zhang T; Zhao L Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):628-634. PubMed ID: 29791065 [TBL] [Abstract][Full Text] [Related]
54. Association between the blood concentrations of ammonia and carnitine/amino acid of schizophrenic patients treated with valproic acid. Ando M; Amayasu H; Itai T; Yoshida H Biopsychosoc Med; 2017; 11():19. PubMed ID: 28690671 [TBL] [Abstract][Full Text] [Related]
55. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status. Hamed SA; Abdella MM Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440 [TBL] [Abstract][Full Text] [Related]
56. Valproate-induced coma: case report and literature review. Duarte J; Macias S; Coria F; Fernandez E; Clavería LE Ann Pharmacother; 1993 May; 27(5):582-3. PubMed ID: 8347908 [TBL] [Abstract][Full Text] [Related]
58. [Cerebral edema with hyperammonemia in valpromide poisoning. Manifestation in an adult, of a partial deficit in type I carbamylphosphate synthetase]. Bourrier P; Varache N; Alquier P; Rabier D; Kamoun P; Lorre G; Alhayek G Presse Med; 1988 Nov; 17(39):2063-6. PubMed ID: 2974563 [TBL] [Abstract][Full Text] [Related]